
|Articles|October 15, 2014
- Gastrointestinal Cancers (Issue 3)
- Volume 3
- Issue 1
Immunotherapy and Viral Therapy for Pancreatic Cancer
Tanios Bekaii-Saab, MD, discusses the future of immunotherapy and viral therapy for the treatment of pancreatic cancer.
Advertisement
Articles in this issue
about 11 years ago
Unanswered Questions Regarding the Treatment of Pancreatic NETsabout 11 years ago
Targeted Agents and Combinations Being Studied in Pancreatic NETsabout 11 years ago
Sequencing Agents for the Treatment of Pancreatic NETsabout 11 years ago
Research on Epidemiology of GIST Identifies Risk Factorsabout 11 years ago
Antiangiogenic Strategies for mCRC Need Further Explorationabout 11 years ago
Coping With Comorbidities in Hepatocellular Cancerabout 11 years ago
Strategies in Surveillance: Hepatocellular CarcinomaAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
2
Exploring the IO Interface: Bridging Knowledge Gaps in Immunotoxicity Management
3
Medication Burden Linked With Acute Care Use in ARSI-Treated Prostate Cancer
4
First-in-Human Data Support Izalontamab in Advanced Epithelial Tumors
5









































